Gai Xiujuan, Huang Shiqi, Zeng Jiang, Chen Jun, Liu Feng, Li Shan, Lv Wenlong, Guo Feibao, Cai Chuanshu, Hong Jinsheng, Su Li
Department of Radiotherapy, Cancer Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, People's Republic of China.
Department of Radiotherapy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical Universisty, Fuzhou, Fujian, 350212, People's Republic of China.
Cancer Manag Res. 2025 Jan 16;17:83-90. doi: 10.2147/CMAR.S492449. eCollection 2025.
To investigate the impact of Intensity-Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT) on hippocampal radiation dosage and psychological status in patients newly diagnosed with nasopharyngeal carcinoma (NPC).
A retrospective analysis was conducted on 269 NPC patients who received initial treatment between January 2013 and April 2022. Patients were categorized into the IMRT group and the VMAT group based on the radiotherapy technique employed. The differences in hippocampal doses for NPC patients at different stages between the two groups were analyzed. The Hospital Anxiety and Depression Scale (HADS) was used to assess patients' anxiety and depression states. Before radiotherapy, patients with anxiety scores (HADS-A) between 0 and 10 points were included to analyze the differences in anxiety occurrence rates between IMRT and VMAT techniques. Similarly, patients with depression scores (HADS-D) between 0 and 10 points were included to analyze the differences in depression occurrence rates between the two radiotherapy techniques.
In patients with T1-2 stage, those treated with IMRT had significantly higher hippocampal doses compared to those treated with VMAT. Furthermore, after radiotherapy, the occurrence rates of anxiety (HADS-A ≥ 11) and depression (HADS-D ≥ 11) in the IMRT group were 27.3% and 19.5%, respectively, while in the VMAT group, they were 9.5% and 7.4%, both showing significant statistical differences (=0.010, =0.035). However, there was no significant correlation between the radiotherapy technique and anxiety or depression occurrence rates in patients with T3-4 stage. Additionally, age and gender exhibited certain influences on psychological status.
In the absence of hippocampal protection, opting for a VMAT treatment plan over IMRT may potentially reduce the incidence of anxiety and depression. This perspective offers new insights for optimizing treatment strategies and improving quality of life.
探讨调强放射治疗(IMRT)和容积调强弧形治疗(VMAT)对新诊断鼻咽癌(NPC)患者海马体放射剂量及心理状态的影响。
对2013年1月至2022年4月期间接受初始治疗的269例NPC患者进行回顾性分析。根据所采用的放射治疗技术将患者分为IMRT组和VMAT组。分析两组不同分期NPC患者海马体剂量的差异。采用医院焦虑抑郁量表(HADS)评估患者的焦虑和抑郁状态。放疗前,纳入焦虑评分(HADS-A)在0至10分之间的患者,分析IMRT和VMAT技术在焦虑发生率上 的差异。同样,纳入抑郁评分(HADS-D)在0至10分之间的患者,分析两种放射治疗技术在抑郁发生率上的差异。
在T1-2期患者中,接受IMRT治疗的患者海马体剂量显著高于接受VMAT治疗的患者。此外,放疗后,IMRT组焦虑(HADS-A≥11)和抑郁(HADS-D≥11)的发生率分别为27.3%和19.5%,而VMAT组分别为9.5%和7.4%,均显示出显著的统计学差异(=0.010,=0.035)。然而,放疗技术与T3-4期患者的焦虑或抑郁发生率之间无显著相关性。此外,年龄和性别对心理状态有一定影响。
在未进行海马体保护的情况下,选择VMAT治疗方案而非IMRT可能会降低焦虑和抑郁的发生率。这一观点为优化治疗策略和提高生活质量提供了新的见解。